Cargando…
Analysis of mTOR Inhibition-Involved Pathway in Ovarian Clear Cell Adenocarcinoma
This study was designed to clarify the mechanism of the mammalian target of rapamycin (mTOR)-hypoxia inducible factor-1 (HIF-1) pathway using the cultured cell strain derived from human ovarian clear cell adenocarcinoma (CCA). Everolimus (a derivative of rapamycin)-treated cells and non-treated cell...
Autores principales: | Harasawa, Makiko, Yasuda, Masanori, Hirasawa, Takeshi, Miyazawa, Masaki, Shida, Masako, Muramatsu, Toshinari, Douguchi, Kensho, Matsui, Naruaki, Takekoshi, Susumu, Kajiwara, Hiroshi, Yoshiyuki Osamura, R., Mikami, Mikio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Japan Society of Histochemistry and Cytochemistry
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096079/ https://www.ncbi.nlm.nih.gov/pubmed/21614172 http://dx.doi.org/10.1267/ahc.10029 |
Ejemplares similares
-
Possible role of thymidine phosphorylase in gynecological tumors as an individualized treatment strategy
por: Shida, Masako, et al.
Publicado: (2016) -
Alterations in Mucin Expression in Ovarian Mucinous Tumors: Immunohistochemical Analysis of MUC2, MUC5AC, MUC6, and CD10 Expression
por: Hirabayashi, Kenichi, et al.
Publicado: (2008) -
Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma
por: Tsukada, Hitomi, et al.
Publicado: (2012) -
Treatment Strategy for Recurrent and Refractory Epithelial Ovarian Cancer: Efficacy of High-Dose Chemotherapy with Hematopoietic Stem Cell Transplantation
por: Muramatsu, Toshinari, et al.
Publicado: (2006) -
An Up-to-Date Anti-Cancer Treatment Strategy Focusing on HIF-1α Suppression: Its Application for Refractory Ovarian Cancer
por: Fujita, Mariko, et al.
Publicado: (2007)